SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-103911
Filing Date
2023-09-26
Accepted
2023-09-26 16:54:59
Documents
18
Period of Report
2023-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326887d1_8k.htm   iXBRL 8-K 50880
2 EXHIBIT 2.1 tm2326887d1_ex2-1.htm EX-2.1 117865
3 EXHIBIT 2.2 tm2326887d1_ex2-2.htm EX-2.2 30721
4 EXHIBIT 10.1 tm2326887d1_ex10-1.htm EX-10.1 38497
5 EXHIBIT 99.1 tm2326887d1_ex99-1.htm EX-99.1 199432
6 EXHIBIT 99.2 tm2326887d1_ex99-2.htm EX-99.2 12129
10 GRAPHIC tm2326887d1_ex99-2img001.jpg GRAPHIC 5611
  Complete submission text file 0001104659-23-103911.txt   706043

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA srne-20230920.xsd EX-101.SCH 3051
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20230920_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20230920_pre.xml EX-101.PRE 22383
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2326887d1_8k_htm.xml XML 3117
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 231281040
SIC: 2836 Biological Products, (No Diagnostic Substances)